ATE523500T1 - Chinazolinon- und isochinolinon-acetamid-derivate - Google Patents
Chinazolinon- und isochinolinon-acetamid-derivateInfo
- Publication number
- ATE523500T1 ATE523500T1 AT07842157T AT07842157T ATE523500T1 AT E523500 T1 ATE523500 T1 AT E523500T1 AT 07842157 T AT07842157 T AT 07842157T AT 07842157 T AT07842157 T AT 07842157T AT E523500 T1 ATE523500 T1 AT E523500T1
- Authority
- AT
- Austria
- Prior art keywords
- isoquinolinone
- quinazolinone
- acetamide derivatives
- acetamide
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84371806P | 2006-09-11 | 2006-09-11 | |
| PCT/US2007/078022 WO2008033764A2 (en) | 2006-09-11 | 2007-09-10 | Quinazolinone and isoquinolinone acetamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE523500T1 true ATE523500T1 (de) | 2011-09-15 |
Family
ID=39184483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07842157T ATE523500T1 (de) | 2006-09-11 | 2007-09-10 | Chinazolinon- und isochinolinon-acetamid-derivate |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7820649B2 (de) |
| EP (1) | EP2069315B1 (de) |
| JP (1) | JP5256202B2 (de) |
| KR (1) | KR20090107994A (de) |
| CN (1) | CN101600698B (de) |
| AR (1) | AR062731A1 (de) |
| AT (1) | ATE523500T1 (de) |
| AU (1) | AU2007296634B2 (de) |
| CA (1) | CA2663161C (de) |
| CL (1) | CL2007002635A1 (de) |
| CO (1) | CO6160322A2 (de) |
| EC (1) | ECSP099177A (de) |
| IL (1) | IL197530A0 (de) |
| MX (1) | MX2009002686A (de) |
| NO (1) | NO20091012L (de) |
| NZ (1) | NZ575426A (de) |
| PE (1) | PE20080841A1 (de) |
| RU (1) | RU2009113612A (de) |
| TW (1) | TW200827352A (de) |
| WO (1) | WO2008033764A2 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010229035A (ja) * | 2007-08-01 | 2010-10-14 | Taisho Pharmaceutical Co Ltd | ピリドピリミジン−４−オン誘導体 |
| WO2009130231A1 (en) * | 2008-04-24 | 2009-10-29 | Glaxo Group Limited | Pyrrolo [1, 2-a] pyrazine derivatives as vasopressin vib receptor antagonists |
| JP5369721B2 (ja) * | 2009-01-30 | 2013-12-18 | 大正製薬株式会社 | ピリドピリミジン−４−オン誘導体 |
| MX2012004289A (es) | 2009-10-13 | 2012-06-12 | Msd Oss Bv | Derivados de azina condensada para el tratamiento de enfermedades relacionadas con el receptor de acetilcolina. |
| DK2623499T3 (da) | 2010-10-01 | 2015-06-08 | Taisho Pharmaceutical Co Ltd | 1,2,4-triazolonderivat |
| BR112014009927B1 (pt) | 2011-10-27 | 2022-07-05 | Taisho Pharmaceutical Co., Ltd | Derivado de azol, composição farmacêutica que o compreende e uso do mesmo |
| SG11201406182PA (en) * | 2012-03-30 | 2014-10-30 | Taisho Pharmaceutical Co Ltd | Fused azole derivative |
| TWI633087B (zh) | 2012-06-13 | 2018-08-21 | 赫孚孟拉羅股份公司 | 新穎二氮雜螺環烷及氮雜螺環烷 |
| SI2900669T1 (sl) | 2012-09-25 | 2019-12-31 | F. Hoffmann-La Roche Ag | Derivati heksahidropirolo(3,4-C)pirola in sorodne spojine kot zaviralci avtotaksina (ATX) in kot zaviralci tvorbe lizofosfatidne kisline (LPA) za zdravljenje npr. bolezni ledvic |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| SI3074400T1 (en) | 2013-11-26 | 2018-03-30 | F. Hoffmann-La Roche Ag | Octahydro-cyclobut (1,2-c, 3,4-cy) dipyrrole derivatives as autoantaxine inhibitors |
| AU2015238537B2 (en) | 2014-03-26 | 2019-08-01 | F. Hoffmann-La Roche Ag | Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors |
| AU2015238541B2 (en) | 2014-03-26 | 2019-09-19 | F. Hoffmann-La Roche Ag | Condensed [1,4]diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors |
| US10030010B2 (en) | 2014-08-04 | 2018-07-24 | Sandoz Ag | Route of synthesis for the preparation of suvorexant |
| US9617226B2 (en) | 2014-09-05 | 2017-04-11 | AbbVie Deutschland GmbH & Co. KG | Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases |
| MA41898A (fr) * | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| PE20180479A1 (es) | 2015-09-04 | 2018-03-07 | Hoffmann La Roche | Nuevos derivados de fenoximetilo |
| JP6845230B2 (ja) | 2015-09-24 | 2021-03-17 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | デュアルａｔｘ／ｃａ阻害剤としての新規な二環式化合物 |
| MA42919A (fr) | 2015-09-24 | 2018-08-01 | Hoffmann La Roche | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
| PE20180552A1 (es) | 2015-09-24 | 2018-04-02 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de atx/ca |
| RU2018114289A (ru) | 2015-09-24 | 2019-10-24 | Ф. Хоффманн-Ля Рош Аг | Бициклические соединения в качестве ингибиторов аутотаксина (atx) |
| EP3386990B1 (de) | 2015-12-09 | 2023-04-19 | Novartis AG | Thienopyrimidinon-nmda-rezeptor-modulatoren und verwendungen davon |
| HUE051395T2 (hu) | 2015-12-09 | 2021-03-01 | Cadent Therapeutics Inc | Heteroaromás NMDA receptor modulátorok és alkalmazásaik |
| ES2975336T3 (es) | 2016-12-22 | 2024-07-04 | Novartis Ag | Moduladores del receptor NMDA y usos de los mismos |
| CN110382484B (zh) | 2017-03-16 | 2022-12-06 | 豪夫迈·罗氏有限公司 | 新的作为atx抑制剂的二环化合物 |
| WO2018167001A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | Heterocyclic compounds useful as dual atx/ca inhibitors |
| PE20210948A1 (es) | 2018-08-03 | 2021-05-24 | Cadent Therapeutics Inc | Moduladores del receptor nmda heteroaromatico y usos de los mismos |
| CN111100063B (zh) * | 2018-10-25 | 2022-05-17 | 南京药石科技股份有限公司 | 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2506767A1 (fr) | 1981-05-26 | 1982-12-03 | Synthelabo | Derives heterocycliques d'amidoximes, leur preparation et leur application en therapeutique |
| CA2288140C (en) | 1997-04-25 | 2007-04-03 | Janssen Pharmaceutica N.V. | Farnesyltransferase inhibiting quinazolinones |
| IL139199A (en) | 1999-11-02 | 2006-10-31 | Nihon Nohyaku Co Ltd | Derivatives of aminoquinazolinone (thion) or their salts, their intermediates, pesticides and method of use |
| FR2804114B1 (fr) | 2000-01-25 | 2002-03-08 | Sanofi Synthelabo | Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant |
| FR2842527B1 (fr) | 2002-07-19 | 2005-01-28 | Sanofi Synthelabo | Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique |
| KR100843053B1 (ko) * | 2004-01-16 | 2008-07-01 | 에프. 호프만-라 로슈 아게 | 중추 신경계 질환의 치료를 위한 5-하이드록시트립트아민수용체(5-ｈｔ)의 조절제로서1-벤질-5-피페라진-1-일-3,4-다이하이드로-1ｈ-퀴나졸린-2-온 유도체 및 각각의1ｈ-벤조(1,2,6)티아다이아진-2,2-다이옥사이드 및1,4-다이하이드로-벤조(ｄ)(1,3)옥사진-2-온 유도체 |
| CA2569081A1 (en) * | 2004-05-31 | 2005-12-08 | Takashi Mizutani | Quinazoline derivative |
| WO2006012577A2 (en) * | 2004-07-22 | 2006-02-02 | Bayer Pharmaceuticals Corporation | Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake |
| TW200643015A (en) * | 2005-03-11 | 2006-12-16 | Akzo Nobel Nv | 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives |
| US7906504B2 (en) * | 2006-09-11 | 2011-03-15 | N.V. Organon | 2-(1-oxo-1H-isoquinolin-2-yl)acetamide derivatives |
-
2007
- 2007-09-10 RU RU2009113612/04A patent/RU2009113612A/ru unknown
- 2007-09-10 NZ NZ575426A patent/NZ575426A/en not_active IP Right Cessation
- 2007-09-10 US US11/852,762 patent/US7820649B2/en active Active
- 2007-09-10 WO PCT/US2007/078022 patent/WO2008033764A2/en active Application Filing
- 2007-09-10 MX MX2009002686A patent/MX2009002686A/es not_active Application Discontinuation
- 2007-09-10 AU AU2007296634A patent/AU2007296634B2/en active Active
- 2007-09-10 KR KR1020097007035A patent/KR20090107994A/ko not_active Application Discontinuation
- 2007-09-10 CN CN2007800416250A patent/CN101600698B/zh active Active
- 2007-09-10 EP EP07842157A patent/EP2069315B1/de active Active
- 2007-09-10 CA CA2663161A patent/CA2663161C/en active Active
- 2007-09-10 AT AT07842157T patent/ATE523500T1/de not_active IP Right Cessation
- 2007-09-10 JP JP2009527608A patent/JP5256202B2/ja active Active
- 2007-09-11 AR ARP070103999A patent/AR062731A1/es not_active Application Discontinuation
- 2007-09-11 PE PE2007001221A patent/PE20080841A1/es not_active Application Discontinuation
- 2007-09-11 CL CL2007002635A patent/CL2007002635A1/es unknown
- 2007-09-11 TW TW096133906A patent/TW200827352A/zh unknown
-
2009
- 2009-03-06 NO NO20091012A patent/NO20091012L/no not_active Application Discontinuation
- 2009-03-11 EC EC2009009177A patent/ECSP099177A/es unknown
- 2009-03-11 IL IL197530A patent/IL197530A0/en unknown
- 2009-04-08 CO CO09036257A patent/CO6160322A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20080841A1 (es) | 2008-06-14 |
| ECSP099177A (es) | 2009-06-30 |
| JP2010502746A (ja) | 2010-01-28 |
| IL197530A0 (en) | 2009-12-24 |
| CO6160322A2 (es) | 2010-05-20 |
| KR20090107994A (ko) | 2009-10-14 |
| MX2009002686A (es) | 2009-10-13 |
| US20080090802A1 (en) | 2008-04-17 |
| CN101600698A (zh) | 2009-12-09 |
| CA2663161A1 (en) | 2008-03-20 |
| AU2007296634A1 (en) | 2008-03-20 |
| US7820649B2 (en) | 2010-10-26 |
| CL2007002635A1 (es) | 2009-10-23 |
| RU2009113612A (ru) | 2010-10-20 |
| EP2069315A4 (de) | 2010-11-03 |
| EP2069315B1 (de) | 2011-09-07 |
| NO20091012L (no) | 2009-03-26 |
| JP5256202B2 (ja) | 2013-08-07 |
| WO2008033764A3 (en) | 2008-12-18 |
| EP2069315A2 (de) | 2009-06-17 |
| NZ575426A (en) | 2010-09-30 |
| WO2008033764A2 (en) | 2008-03-20 |
| TW200827352A (en) | 2008-07-01 |
| AU2007296634B2 (en) | 2012-09-20 |
| CN101600698B (zh) | 2012-01-11 |
| AR062731A1 (es) | 2008-11-26 |
| CA2663161C (en) | 2014-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE523500T1 (de) | Chinazolinon- und isochinolinon-acetamid-derivate | |
| BRPI0720909A2 (pt) | derivados de isoquinolina e isoquinolinona substituídos | |
| DE602007010981D1 (de) | Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate | |
| DE602007010272D1 (de) | Parkhilfevorrichtung und parkhilfeverfahren | |
| ATE413389T1 (de) | Chinazolinderivate | |
| SMT201400193B (it) | Isochinolinoni e chinazolinoni sostituiti | |
| BRPI0716300A2 (pt) | Artigo e mistura | |
| CR10813A (es) | Derivados de isoquinolona sustituidos con cicloalquilamina | |
| DE602007003585D1 (de) | Klappbarer und höhenverstellbarer kinderwagen | |
| DK1984322T3 (da) | Benzamid- og heteroarenderivater | |
| ZA200903552B (en) | Substituted isoquinoline and isoquinolinone derivatives | |
| BRPI0813355A2 (pt) | Compostos de quinazolinona e métodos de uso dos mesmos | |
| DE602007006394D1 (de) | Mikrofon und Befestigungsanordnung | |
| DE602006015540D1 (de) | Durchführung und buchse | |
| DK1854789T3 (da) | Quinazolinderivat med tyrosin-kinase inhibitorisk aktivitet | |
| CR9458A (es) | Quinolonas y naftiridonas 7-amino alquilidenil heterociclicas | |
| DK2001891T3 (da) | Buprenorfinderivater samt anvendelser deraf | |
| DE602007011305D1 (de) | Kaffee- und teedosiersystem | |
| SE0700997L (sv) | Fastsättningsapparat och -system | |
| FI20060864A0 (fi) | Integroitu systeemi, laite ja niiden käyttö | |
| DK1974592T3 (da) | Kølesystem og -fremgangsmåde | |
| ATE523493T1 (de) | 2-(1-oxo-1h-isochinolin-2-yl) acetamid-derivate | |
| DE102007013751B8 (de) | Tiefpassfilter und Tiefpassfilter-Anordnung | |
| DE602006019003D1 (de) | Verstärkerschaltung und integrierte schaltung dafür | |
| DE112007001727A5 (de) | Fordereinheit und Forderverfahren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |